Trial intelligence / Profile preview

Mesenchymal stem cell transplantation for diabetes mellitus

ChiCTR-TRC-11001219Phase 2Completed

Sponsor
Endocrinologlst of Xinqiao Hospital of Chongqi Province in China
Start
Jun 2009
Modality
Stem Cell Therapies → Cell Therapies
Countries
1
01

Overview

A Phase 2 trial of mesenchymal stem cells in diabetes mellitus (DM), sponsored by Endocrinologlst of Xinqiao Hospital of Chongqi Province in China. Started Jun 2009; status: completed.

02

Drugs

mesenchymal stem cells
03

Conditions

diabetes mellitus (DM)

Beyond the preview

Go deeper on ChiCTR-TRC-11001219.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-11001219.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call